Browsing by Author Menzies, Alexander Maxwel

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 67  next >
Issue DateTitleAuthor(s)Citation
2015Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanismsKefford, Richard (Rick); Long, Georgina; Menzies, Alexander Maxwel; Pupo, Gulietta; Rizos, Helen; Scolyer, Richard; Thompson, John; Becker, Jurgen C; Berking, Carola; Eroglu, Zeynep; et al, Various; Gogas, Helen; Gutzmer, R.; Johnson, Douglas B; Sucker, Antje; Ye, Fei; Zhao, Shilin; Zimmer, Lisa; Western Clinical School: Westmead Institute for Medical Res; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Institute for Medical Res; Central Clinical School: Pathology; Central Clinical School: SurgeryAcquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms, European Journal of Cancer, vol.51, 18, 2015,pp 2792-2799
2016Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanomaCarlino, Matteo; Fogarty, Gerald; Guminski, Alexander; Hong, Angela; Kefford, Richard (Rick); Liniker, Elizabeth; Lo, Serigne; Long, Georgina; Menzies, Alexander Maxwel; Ramanujam, Sangeetha; Cooper, Adam; Kong, Benjamin; Wang, T. W.; Western Clinical School: Medicine (Westmead); Northern Clinical School: Medicine; Northern Clinical School: Medicine; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Central Clinical School: Melonoma & Skin Cancer Res. Inst.; The George Institute for Global Health; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Central Clinical School: Melonoma & Skin Cancer Res. Inst.Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanoma, OncoImmunology, vol.5, 9, 2016,pp 1-7
2017Advanced cancer patients' attitudes towards, and experiences with, screening for somatic mutations in tumours: a qualitative studyLong, Georgina; Menzies, Alexander Maxwel; Chin, Melvin; Harris-Wai, J.; Kasparian, Nadine A; Kaur, R.; Lewis, C; Liang, R.; Meiser, B.; Smith, Sian; Ward, R; Northern Clinical School: Medicine; Northern Clinical School: MedicineAdvanced cancer patients' attitudes towards, and experiences with, screening for somatic mutations in tumours: a qualitative study, European Journal of Cancer Care, vol.26, 6, 2017,pp 1-11
2017Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumabCarlino, Matteo; Guminski, Alexander; Long, Georgina; Menzies, Alexander Maxwel; Park, John; Ramanujam, Sangeetha; Atkinson, V; Eroglu, Z; et al, Various; Johnson, Douglas B; Klein, O; McQuade, J; Shoushtari, A; Tsai, K. K.; Wong, Annie; Western Clinical School: Medicine (Westmead); Northern Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Melonoma & Skin Cancer Res. Inst.Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab, Annals of Oncology, vol.28, 2, 2017,pp 368-376
2018CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naive Melanoma Patients and Expand Significantly During Anti-PD-1 TreatmentBritton, Warwick; Chen, Jinbiao; Edwards, Jarem; Ferguson, Angela; Gide, Tuba; Hersey, Peter; Hewavisenti, Rehana; Long, Georgina; Madore, Jason; Menzies, Alexander Maxwel; Palendira, Umaimainthan; Quek, Camelia; Saw, Robyn; Scolyer, Richard; Tasker, Annie; Thompson, John; Weninger, Wolfgang; Wilmott, James; Gebhardt, Thomas; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; Medicine; Physiology; Northern Clinical School: Surgery; Veterinary Science; Northern Clinical School: Medicine; Central Clinical School: Medicine; Northern Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Surgery; Central Clinical School: Pathology; Charles Perkins Centre; Central Clinical School: Surgery; Central Clinical School: Centenary Institute; Central Clinical School: SurgeryCD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naive Melanoma Patients and Expand Significantly During Anti-PD-1 Treatment, Clinical Cancer Research, vol.24, 13, 2018,pp 3036-3045
2015Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase 1/2 clinical trialKefford, Richard (Rick); Long, Georgina; Menzies, Alexander Maxwel; Ashworth, Michelle T; et al, Various; Flaherty, Keith; Gonzalez, Rene; Hamid, Omid; Infante, Jeffrey; Kim, K B; Schuchter, Lynn; Swann, S; Weber, Jeffrey; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: MedicineCharacteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase 1/2 clinical trial, Annals of Oncology, vol.26, 2, 2015,pp 415-421
2017Clinical significance of intronic variants in BRAF inhibitor resistant melanomas with altered BRAF transcript splicingCarlino, Matteo; Kefford, Richard (Rick); Long, Georgina; Menzies, Alexander Maxwel; Pedersen, Bernadette; Pupo, Gulietta; Rizos, Helen; Scolyer, Richard; Boyd, Suzanah C; Fung, Carina; Hayward, Nicholas K; Johansson, Peter; Westmead Clinical School: Medicine; Westmead Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Westmead Clinical School: Westmead Institute for Medical Res; Westmead Clinical School: Medicine; Westmead Clinical School: Westmead Institute for Medical Res; Central Clinical School: PathologyClinical significance of intronic variants in BRAF inhibitor resistant melanomas with altered BRAF transcript splicing, Biomarker Research, vol.5, 17, 2017,pp 1-4
2015Clinicopathologic features associated with efficacy and long-term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitorsCarlino, Matteo; Drummond, Martin John; Guminski, Alexander; Kefford, Richard (Rick); Lo, Serigne; Long, Georgina; Lyle, Megan; Menzies, Alexander Maxwel; Scolyer, Richard; Thompson, John; Wilmott, James; Chan, Matthew M K; Western Clinical School: Medicine (Westmead); School of Public Health: Public Health; Medicine Faculty Office; Western Clinical School: Westmead Institute for Medical Res; The George Institute for Global Health; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Central Clinical School: Medicine; Central Clinical School: Pathology; Central Clinical School: Surgery; Central Clinical School: SurgeryClinicopathologic features associated with efficacy and long-term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitors, Cancer, vol.121, 21, 2015,pp 3826-3835
2016Comparison of whole-exome sequencing of matched fresh and formalin fixed paraffin embedded melanoma tumours: implications for clinical decision makingKakavand, Hojabr; Long, Georgina; Mann, Graham; Menzies, Alexander Maxwel; Pupo, Gulietta; Scolyer, Richard; Wilmott, James; De Paoli-Iseppi, Ricardo; Dias, Kerith-Rae; Dinger, Marcel; Hayward, Nicholas K; Johansson, Peter; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Central Clinical School: The Sydney Cancer Centre; Western Clinical School: Westmead Institute for Medical Res; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Central Clinical School: Pathology; Central Clinical School: SurgeryComparison of whole-exome sequencing of matched fresh and formalin fixed paraffin embedded melanoma tumours: implications for clinical decision making, Pathology, vol.48, 3, 2016,pp 261-266
2014Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanomaCarlino, Matteo; Hamilton, Anne; Haydu, Lauren; Kakavand, Hojabr; Kefford, Richard (Rick); Long, Georgina; Menzies, Alexander Maxwel; O'Toole, Sandra; Scolyer, Richard; Thompson, John; Yu, Bing; Cooper, Wendy; Ng, C; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; Central Clinical School: Surgery; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Medicine; Central Clinical School: Pathology; Central Clinical School: Pathology; Central Clinical School: Surgery; Central Clinical School: MedicineCorrelation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma, British Journal of Cancer, vol.111, 2, 2014,pp 292-299
2015Cutaneous Toxic Effects of BRAF Inhibitors Alone and in Combination With MEK Inhibitors for Metastatic MelanomaAnforth, Rachael; Carlino, Matteo; Carlos, Giuliana R M; Clements, Arthur; Fernandez Penas, Pablo; Menzies, Alexander Maxwel; Chou, Shaun; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Central Clinical School: MedicineCutaneous Toxic Effects of BRAF Inhibitors Alone and in Combination With MEK Inhibitors for Metastatic Melanoma, JAMA Dermatology, vol.151, 10, 2015,pp 1103-1109
2014Dabrafenib and Trametinib, Alone and in Combination for BRAF-Mutant Metastatic MelanomaLong, Georgina; Menzies, Alexander Maxwel; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: MedicineDabrafenib and Trametinib, Alone and in Combination for BRAF-Mutant Metastatic Melanoma, Clinical Cancer Research, vol.20, 8, 2014,pp 2035-2043
2016Dose escalation of tamoxifen in patients with low endoxifen level: Evidence for therapeutic drug monitoring - The TADE studyBalleine, Rosemary; Gao, Bo-Fu; Gebski, Val; Gurney, Howard; Hui, Rina; Kefford, Richard (Rick); Lee, Clara; Liddle, Christopher; Menzies, Alexander Maxwel; Provan, Pamela; Wilcken, Nicholas; Wong, Ka (Mark); Ali, Sayed Sahanawaz; Balakrishnar, Bavanthi; Coulter, Sally A.; Fox, Peter; Lynch, Jodi; Yeap, Shang Heng; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Institute for Medical Res; Western Clinical School (Westmead): Office; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead)Dose escalation of tamoxifen in patients with low endoxifen level: Evidence for therapeutic drug monitoring - The TADE study, Clinical Cancer Research, vol.22, 13, 2016,pp 3164-3171
2017Dynamic changes in PD-L1 expression and immune infiltrates early during treatment predict response to PD-1 blockade in MelanomaCarlino, Matteo; Guminski, Alexander; Jakrot, Valerie; Kakavand, Hojabr; Kefford, Richard (Rick); Liniker, Elizabeth; Lo, Serigne; Long, Georgina; Madore, Jason; Menzies, Alexander Maxwel; Saw, Robyn; Scolyer, Richard; Thompson, John; Vilain, Ricardo; Wilmott, James; Cooper, Adam J.; Howle, Julie; Kong, Benjamin; Westmead Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Westmead Clinical School: Medicine; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Central Clinical School: Medicine; Northern Clinical School: Medicine; Central Clinical School: Medicine; Northern Clinical School: Medicine; Central Clinical School: Surgery; Central Clinical School: Pathology; Central Clinical School: Surgery; Central Clinical School: Pathology; Central Clinical School: SurgeryDynamic changes in PD-L1 expression and immune infiltrates early during treatment predict response to PD-1 blockade in Melanoma, Clinical Cancer Research, vol.23, 17, 2017,pp 5024-5033
2014Dynamics of chemokine, cytokine, and growth factor serum levels in BRAF-mutant melanoma patients during BRAF inhibitor treatmentHaydu, Lauren; Hersey, Peter; Kefford, Richard (Rick); Long, Georgina; Menzies, Alexander Maxwel; Scolyer, Richard; Thompson, John; Wilmott, James; Hyman, Jessica; Lum, Trina; Central Clinical School: Surgery; Northern Clinical School: Surgery; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Medicine; Central Clinical School: Pathology; Central Clinical School: Surgery; Central Clinical School: SurgeryDynamics of chemokine, cytokine, and growth factor serum levels in BRAF-mutant melanoma patients during BRAF inhibitor treatment, The Journal of Immunology, vol.192, 5, 2014,pp 2505-2513
2017Efficacy of anti-PD-1 therapy in patients with melanoma brain metastasesCarlino, Matteo; Drummond, Martin; Guminski, Alexander; Kefford, Richard (Rick); Lo, Serigne; Long, Georgina; Menzies, Alexander Maxwel; Park, John; Rai, Rajat; Andrews, Miles C; Cebon, Jonathan Simon; Haydon, Andrew; Klein, O; McArthur, Grant A.; Mendis, S; Parakh, S; Rowe, Catherine; Wong, Annie; Xu, Wen; Western Clinical School: Medicine (Westmead); School of Public Health: Public Health; Northern Clinical School: Medicine; Western Clinical School: Medicine (Westmead); The George Institute for Global Health; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: MedicineEfficacy of anti-PD-1 therapy in patients with melanoma brain metastases, British Journal of Cancer, vol.116, 12, 2017,pp 1558-1563
2015Epigenetic Changes of EGFR Have an Important Role in BRAF Inhibitor-Resistant Cutaneous MelanomasLong, Georgina; Menzies, Alexander Maxwel; Scolyer, Richard; Chong, Kelly; Hoon, D; Hsu, Sandy; Huang, Sharon K; Izraely, Sivan; Kawas, Neal P; Marzese, Diego M; Sagi-Assif, Orit; Wang, Jinhua; Witz, Isaac P; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Medicine; Central Clinical School: PathologyEpigenetic Changes of EGFR Have an Important Role in BRAF Inhibitor-Resistant Cutaneous Melanomas, Journal of Investigative Dermatology, vol.135, 2, 2015,pp 532-541
2014Evaluation of stromal HGF immunoreactivity as a biomarker for melanoma response to RAF inhibitorsKefford, Richard (Rick); Long, Georgina; Menzies, Alexander Maxwel; Scolyer, Richard; Thompson, John; Larson, Allison; Lee, Chung-Wei; Lezcano, Cecilia; Mihm, Martin C Jr; Murphy, George; Ogino, Shuji; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Medicine; Central Clinical School: Pathology; Central Clinical School: SurgeryEvaluation of stromal HGF immunoreactivity as a biomarker for melanoma response to RAF inhibitors, Modern Pathology, vol.27, 9, 2014,pp 1193-1202
2017Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patientsCarlino, Matteo; Long, Georgina; Menzies, Alexander Maxwel; Scolyer, Richard; Ahn, Seong Beom; Breen, Edmond; Kefford, Richard F.; Khan, Alamgir; Lee, Jenny H.; Lim, Su Yin; Rizos, Helen; Welsh, Sarah; Westmead Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Central Clinical School: PathologyEvaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patients, Biomarker Research, vol.5, N/A, 2017,pp 1-12
2015Factors influencing the development of cutaneous squamous cell carcinoma in patients on BRAF inhibitor therapyAnforth, Rachael; Byth Wilson, Karen; Carlos, Giuliana R M; Fernandez Penas, Pablo; Kefford, Richard (Rick); Long, Georgina; Menzies, Alexander Maxwel; Scolyer, Richard; Sharma, Raghwa; Chou, Shaun; Western Clinical School: Medicine (Westmead); NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Medicine; Central Clinical School: Pathology; Western Clinical School: PathologyFactors influencing the development of cutaneous squamous cell carcinoma in patients on BRAF inhibitor therapy, Journal Of The American Academy Of Dermatology, vol.72, 5, 2015,pp 809-815.e1